Sort by
Refine Your Search
-
and Technology (CST) at the University of Cambridge. The goal of this PhD programme is to launch one "deceptive by design" project that combines the perspectives of human-computer interaction (HCI) and
-
, develop business cases and more. At the 6-month point, students progress onto their interdisciplinary PhD research project, supervised jointly by two academics from two research groups. Usually, supervisors
-
Location: West Cambridge The world-renowned Cavendish Laboratory is seeking an enthusiastic, self-motivated student who enjoys working as part of a team to undertake a PhD in the NanoPhotonics Group
-
non-clinical PhD studentship in cardiometabolic research, commencing October 2026 in the Department of Medicine (VPD Heart & Lung Research Institute), University of Cambridge. The project will be based
-
We invite applications from creative and motivated individuals to join Professor Sir Shankar Balasubramanian's group for a 4-year PhD studentship, working on a multidisciplinary project exploiting
-
also throughout the development phase, which involves transforming a molecule into a medicine and addressing various chemistry, manufacturing, and control (CMC) challenges. A key aspect of this process
-
Researcher Profile First Stage Researcher (R1) Positions PhD Positions Country United Kingdom Application Deadline 15 Sep 2025 - 23:59 (Europe/London) Type of Contract Temporary Job Status Full-time Offer
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
scholarships or funding schemes. Students will not be allowed to supplement fees via self-funding. Application process: Please click on the 'Apply' button above to apply for a PhD in Biochemistry via
-
Supervisors: Dr Tim Halim and Dr Gregory Hamm Course start: 1st October 2026 Overview The project will be supervised by Dr Tim Halim, Dr Albert Koulman (Institute of Metabolic Science) and Dr Gregory Hamm (AstraZeneca). Project details The tumour immunity cycle involves cyclical trafficking of...